.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
UBS
McKesson
Federal Trade Commission
Queensland Health
Covington
Cipla
Chinese Patent Office
Cerilliant
Healthtrust

Generated: July 22, 2017

DrugPatentWatch Database Preview

Tentative Approvals for: Hetero Labs Ltd Iii

« Back to Dashboard
Applicant Generic Name NDA Strength Dosage Form
Hetero Labs Ltd Iii
raltegravir
203540400MGTABLET;ORAL
Hetero Labs Ltd Iii
lopinavir; ritonavir
091677200MG; 50MGTABLET; ORAL
Hetero Labs Ltd Iii
lamivudine; tenofovir disoproxil fumarate; nevirapine
205355300MG; 300MG; 200MGTABLET; ORAL
Hetero Labs Ltd Iii
lamivudine
09147510MG/MLSOLUTION; ORAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
QuintilesIMS
UBS
AstraZeneca
Baxter
Novartis
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot